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Summary
Background:  Although  drug-eluting  stents  (DES)  have  considerably  reduced  the  incidence  of  in-
stent restenosis,  late  and  very  late  stent  thrombosis  (ST)  after  DES  implantation  have  emerged
as major  safety  concerns.  We  morphologically  investigated  the  age  of  DES  thrombi  aspirated
during percutaneous  coronary  intervention  (PCI)  from  patients  with  either  late  or  very  late  ST
that resulted  in  acute  myocardial  infarction  (AMI).
Methods  and  results:  We  obtained  DES  thrombi  during  PCI  from  16  consecutive  patients  with
ST (late  and  very  late  ST,  n  =  4  and  n  =  12,  respectively),  who  presented  with  AMI  within  24  h
of the  onset  of  anginal  symptoms.  Thrombi  were  morphologically  classiﬁed  as  fresh,  lytic,  and
organized.  Fresh  thrombus  was  identiﬁed  in  5  (31%)  of  the  16  patients  and  lytic  thrombus  was
found in  3  (19%).  Organized  thrombus  was  notably  found  in  8  (50%)  patients,  of  whom  5  (31%)
had only  the  organized  type  and  3  (19%)  had  both  fresh  and  organized  thrombi.  The  frequency
of fresh  thrombus  tended  to  be  higher  in  patients  with  stent  failure  such  as  stent  malapposition
and fracture,  but  the  difference  did  not  reach  signiﬁcance  (p  =  0.06).
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Conclusions:  Although  the  study  g
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rug-eluting  stents  (DES)  signiﬁcantly  reduce  the  inci-
ence  of  in-stent  restenosis  compared  with  bare-metal
tents  among  patients  with  coronary  heart  disease  who
ndergo  percutaneous  coronary  intervention  (PCI)  [1,2].
owever,  late  (LST)  and  very  late  stent  thrombosis  (VLST)
fter  DES  implantation  have  emerged  as  major  safety  con-
erns  [3,4]. Clinical  and  pathological  studies  have  revealed
hat  delayed  arterial  healing,  incomplete  endothelializa-
ion,  stent  malapposition,  persistent  ﬁbrin  deposition,  and
hronic  inﬂammation  are  associated  with  DES  thrombosis,
nd  thrombus  has  been  detected  in  stented  segments  even
mong  asymptomatic  patients  [3,5—8]. We  and  others  have
lso  suggested  that  organized  thrombus  develops  in  patients
ith  VLST  [9—11]. These  lines  of  evidence  indicate  a  consid-
rable  interval  between  the  onset  of  DES  thrombosis  and  the
ccurrence  of  symptoms.  At  present  little  attention  has  been
iven  to  this  aspect.  We  therefore  histopathologically  inves-
igated  the  age  of  DES  thrombi  aspirated  during  coronary
ntervention  from  patients  with  either  LST  or  VLST  resulting
n  acute  myocardial  infarction  (AMI).  Our  ﬁndings  provide
urther  information  regarding  another  potential  mechanism
f  DES  thrombosis.
ethods
tudy  patients
n  3400  patients  who  underwent  DES  implantation,  we
ecruited  17  consecutive  patients  (5  and  12  with  deﬁnite
ST  and  VLST,  respectively)  who  presented  at  our  insti-
utions  with  AMI  between  July  2005  and  December  2010.
ll  of  them  were  treated  by  percutaneous  intracoronary
hrombectomy  during  emergency  PCI.  Since  the  thrombus  in
ne  patient  with  LST  was  not  suitable  for  histological  assess-
ent  (≤1  mm2),  the  study  cohort  ﬁnally  comprised  4  and  12
atients  with  LST  with  VLST,  respectively.  The  Ethics  Com-
ittees  at  both  institutions  approved  the  protocol  of  the
tudy,  in  which  patients  provided  written  informed  consent
o  participate.
Deﬁnite  stent  thrombosis  (ST)  was  deﬁned  as  the  asso-
iation  of  clinical  symptoms  with  angiographic  conﬁrmation
f  thrombotic  stent  occlusion  in  accordance  with  the  Aca-
emic  Research  Consortium  deﬁnition  [3,5]. The  timing  of
T  was  categorized  as  late  (L)  and  very  late  (VL)  when  ST
ccurred  between  one  month  and  one  year  after  DES  implan-
ation,  and  at  over  one  year  thereafter  [3,5]. The  diagnosis
f  AMI  was  based  on  a  history  of  typical  chest  pain  persisting
or  ≥30  min,  characteristic  electrocardiogram  changes  and
levated  creatine  kinase  (>2-fold  the  upper  limit  of  normal)
ithin  24  h  after  the  onset  of  pain.
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roup  is  small,  about  two-thirds  of  DES  thrombi  in  late  and  very
ese  ﬁndings  suggest  an  important  discrepancy  between  the  time
botic  process  and  the  occurrence  of  acute  clinical  symptoms,
bout  another  potential  mechanism  of  DES  thrombosis.
on  behalf  of  Japanese  College  of  Cardiology.
hrombectomy  procedure
atients  who  were  not  administered  with  anti-platelet  drugs
pon  admission  were  treated  with  aspirin  (loading  dose,
00  mg)  and  clopidogrel  (loading  dose,  300  mg).  Procedu-
al  anticoagulation  therapy  included  heparin  targeted  to
n  activated  clotting  time  of  200—300  s.  Sites  of  throm-
otic  stent  occlusion  were  identiﬁed  by  angiography  using
 6F  guiding  catheter.  A  0.014-in.  coronary  guidewire  was
hen  passed  through  the  affected  stent,  followed  by  throm-
us  aspiration  using  a  custom-designed  aspiration  catheter
Thrombuster,  Kaneka  Co.,  Tokyo,  Japan),  which  is  a  rapid
xchange  catheter  with  a  large  aspiration  lumen  and  soft,
exible,  non-traumatic  tip  [11,12],  before  any  other  inter-
ention.  Where  possible,  we  assessed  whether  the  age
f  the  DES  thrombus  was  related  to  stent  failure  such
s  stent  fracture,  underexpansion,  and  incomplete  appo-
ition  using  intravascular  ultrasound  (IVUS)-guided  PCI.  All
atients  underwent  PCI  according  to  current  guidelines,  and
he  PCI  devices  were  selected  at  the  discretion  of  the  oper-
tors.
istopathological  sampling  and  analysis
spirated  materials  were  immediately  ﬁxed  in  4%
araformaldehyde  and  then  parafﬁn-embedded  sec-
ions  (4  m  thick)  were  stained  with  hematoxylin  and  eosin
or  morphological  evaluation.  If  the  amount  of  material
as  sufﬁcient  (>1  mm2),  thrombi  were  classiﬁed  according
o  published  and  histopathologically  accepted  deﬁnitions
13—15]  as:  fresh,  comprising  layers  of  platelets,  ﬁbrin,
rythrocytes,  and  intact  granulocytes;  lytic,  characterized
y  areas  of  colliquation  necrosis  and  karyorrhexis  of  gran-
locytes;  and  organized,  with  features  of  smooth  muscle
ell  ingrowth  with  or  without  connective  tissue  deposition
nd  capillary  vessel  ingrowth.  Heterogeneous  thrombus
aterial  was  graded  according  to  the  age  of  the  oldest
ortion  (Fig.  1).  To  conﬁrm  the  compositions  of  thrombi,
erial  sections  were  also  examined  immunohistochemically
sing  primary  antibodies  against  -smooth  muscle  actin
smooth  muscle  cells,  Dako  Japan  Inc.,  Kyoto,  Japan),  CD34
endothelial  cells,  Dako  Japan  Inc.),  platelet  glycoprotein
GP)  IIb/IIIa  (Afﬁnity  Biologicals  Inc.,  Hamilton,  CA,  USA),
nd  ﬁbrin  (Accurate  Chemical  &  Scientiﬁc  Corp.,  Westbury,
Y,  USA).  The  sections  were  stained  using  EnVision+  kits
Dako  Japan  Inc.).  Horseradish  peroxidase  activity  was
isualized  with  3,3′-diaminobenzidine  containing  hydrogen
eroxide.  Immunopositive  areas  were  semiquantiﬁed  using color  imaging  analysis  system  (Win  Roof,  Mitani,  Fukui,
apan)  and  are  expressed  as  the  ratio  of  positively  stained
reas  per  total  tissue  as  described  [11]. Two  investiga-
ors  (K.  Nishihira  and  K.  Hatakeyama)  who  were  blinded
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Figure  1  Representative  microphotographs  of  aspirated  thrombi  from  patients  with  stent  thrombosis  (hematoxylin  and  eosin
stain). (A)  Low-power  view  of  fresh  thrombus  shows  layered  appearance.  (B)  Detail  of  panel  A  shows  intact  blood  cells  (platelets,
erythrocytes, and  intact  granulocytes)  among  ﬁbrin.  (C)  Low-power  view  of  lytic  thrombus  with  homogeneous  structural  elements
indicates old  thrombus  of  1—2  days.  (D)  Detail  of  panel  C  shows  nuclear  swelling,  fragmentation  and  nuclear  dust.  (E)  Overview  of
organized thrombus  indicates  old  thrombus  of  >5  days.  (F)  Detail  of  panel  E  shows  ingrowth  of  spindle-shaped  cells  (indicated  by
arrows) and  collagen  deposition.  (G)  Detail  of  panel  E  shows  capillary  vessel  ingrowth  (indicated  by  arrows).
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Table  1  Baseline  clinical  and  angiographic  characteristics
of patients  with  late  and  very  late  stent  thrombosis  (n  =  16).
Age  (years) 65  ±  13
Male sex,  n  (%) 13  (81)
Timing of  ST
LST,  n  (%)  4  (25)
VLST, n  (%)  12  (75)
Elapsed  time  after  DES  implantation  (m)  37  ±  21
Risk factors
Diabetes  mellitus,  n  (%)  5  (31)
Hypertension,  n  (%)  10  (63)
Dyslipidemia,  n  (%) 12  (75)
Current  smoking,  n  (%) 5  (31)
Obesity,  n  (%)  3  (19)
Dual antiplatelet  therapy,  n  (%)  7  (44)
Statin use,  n  (%)  7  (44)
Preinfarction  angina,  n  (%)  4  (25)
STEMI,  n  (%)  13  (81)
Total ischemic  time  (h)  6.0  ±  6.5
Culprit vessel
Left  main  trunk,  n  (%)  1  (6)
Left anterior  descending,  n  (%)  7  (44)
Left circumﬂex,  n  (%)  1  (6)
Right coronary  artery,  n  (%)  7  (44)
Pre-procedural  TIMI  ﬂow  0—1,  n  (%)  13  (81)
DES stent  type
Sirolimus-eluting  stent,  n  (%)  14  (87.5)
Paclitaxel-eluting  stent,  n  (%) 2  (12.5)
Stent diameter  (mm)  3.1  ±  0.4
Stent length  (mm) 23.4  ±  5.8
Values are means ± SD or percentages. ST: stent thrombosis, LST:
late stent thrombosis, VLST: very late stent thrombosis, DES:0  
o  the  patients’  clinical  classiﬁcation  morphometrically
nalyzed  the  specimens.
tatistical  analysis
ata  are  expressed  as  means  ±  SD.  Differences  between  two
roups  were  analyzed  using  an  unpaired  Student’s  t-test  or
he  Mann-Whitney  U  test  when  variance  was  skewed.  Cate-
orical  variables  were  compared  using  the  2 test  or  Fisher’s
xact  test.  Linear  regression  analyses  evaluated  relation-
hips  between  the  factors.  All  tests  were  two-sided  and  a
-value  of  <  0.05  was  considered  statistically  signiﬁcant.
esults
ables  1  and  2  list  the  baseline  clinical  and  angiographic
haracteristics  of  the  patients  with  late  and  very  late  ST.
he  total  duration  of  ischemia  was  6.0  ±  6.5  h,  and  4  (25%)
f  the  16  patients  experienced  symptoms  of  preinfarction
ngina  during  the  days  or  weeks  before  AMI  presented.
All  DES  thrombi  were  composed  of  aggregated  platelets
nd  ﬁbrin  (Fig.  2).  Fresh  thrombi  were  identiﬁed  in  5  (31%)
f  the  16  patients,  and  lytic  thrombi  were  found  in  3  (19%).
rganized  thrombi  were  found  in  8  (50%)  patients,  of  whom
 (31%)  had  only  the  organized  type  and  3  (19%)  had  both
resh  and  organized  types  (Figs.  2  and  3).  Lytic  or  orga-
ized  changes  compatible  with  an  origin  of  days  or  weeks
efore  the  occlusive  event  were  evident  in  11  (69%)  of  the
6  patients  (Table  2  and  Fig.  3).  The  clinical  characteris-
ics  including  total  ischemic  duration  did  not  signiﬁcantly
iffer  (4.5  ±  5.4  h  vs.  6.6  ±  7.1  h,  p  =  0.56)  between  patients
ith  fresh  and  older  thrombus.  Immunopositive  areas  of  GPIb/IIIa  and  ﬁbrin  did  not  correlate  with  ischemic  time  (GP
Ib/IIIa,  p  =  0.21;  ﬁbrin,  p  =  0.85,  respectively).  And  then,
ual  antiplatelet  therapy  did  not  inﬂuence  thrombus  age
p  >  0.99).
drug-eluting stent, STEMI: ST-elevation myocardial infarction,
Total ischemic time: time between onset of symptoms and nee-
dle time, and TIMI: thrombolysis in myocardial infarction.
Table  2  Summary  of  clinical  and  pathological  ﬁndings  in  16  patients  with  stent  thrombosis.
No.  Age  (y)  Sex  Time  to
ST  (m)
Target
lesion  artery
DES  type  Pre-procedural
angiography
Stent  failure
conﬁrmed  by  IVUS
Thrombus  age
1  75  F  11  RCA  SES  Occlusive  No  Organized
2 70  M  5  LAD  PES  Occlusive  No  Lytic
3 73  F  8  LCX  PES  Occlusive  No  Organized
4 75  M  9  RCA  SES  Occlusive  Yes  Fresh
5 67  M  39  LAD  SES  Occlusive  Yes  Organized
6 51  M  43  RCA  SES  Occlusive  No  Lytic
7 79 M  21  RCA  SES  Occlusive  Yes  Fresh
8 48  M  44  LMT  SES  Not  occlusive  Yes  Fresh
9 57 M  36  LAD  SES  Not  occlusive  Yes  Fresh
10 73 M 48  RCA  SES  Occlusive  No  Lytic
11 50 M 65 LAD  SES  Occlusive  Not  done  Fresh
12 69  M  28  LAD  SES  Occlusive  Not  done  Organized
13 41  M  54  LAD  SES  Not  occlusive  Yes  Organized
14 81  F  58  RCA  SES  Occlusive  Not  done  Organized
15 75  M  64  LAD  SES  Occlusive  Not  done  Organized
16 50  M  60  RCA  SES  Occlusive  Not  done  Organized
ST: stent thrombosis, DES: drug-eluting stent, IVUS: intravascular ultrasound, F: female, M: male, RCA: right coronary artery, SES:
sirolimus-eluting stent, LAD: left anterior descending, PES: paclitaxel-eluting stent, LCX: left circumﬂex, and LMT: left main trunk.
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Figure  2  Representative  coronary  angiogram  and  light  microphotograph  of  a  patient  with  very  late  stent  thrombosis.  (A)  Sirolimus-
eluting stent  (SES;  CypherTM,  Cordis/Johnson  &  Johnson,  Warren,  NJ,  USA)  implanted  at  the  ostial  left  anterior  descending  coronary
artery of  a  69-year-old  male  patient.  Twenty-eight  months  later,  he  presented  with  very  late  stent  thrombosis.  Coronary  angiogram
shows total  occlusion  at  previous  SES  site  (indicated  by  arrows).  (B)  Thrombus  aspirated  from  organized  areas.  (C)  Immunohistochem-
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stent thrombi  were  composed  of  aggregated  platelets  and  ﬁbrin
We  performed  IVUS-guided  PCI  in  11  of  the  16  patients,
of  whom  6  had  stent  failure  (5  with  incomplete  stent  appo-
sition  and  1  with  stent  fracture).  Fresh  thrombus  tended
to  be  more  frequent  in  patients  with  stent  failure,  but  the
difference  did  not  reach  signiﬁcance  (p  =  0.06)  (Table  2).
In  addition,  we  also  compared  the  incidence  of  older
thrombus  (lytic  and  organized  thrombus)  in  de  novo  AMI
patients  (n  =  118)  with  that  in  ST  patients.  However,  the  inci-
dence  of  older  thrombus  was  comparable  between  the  two
groups  (62%  vs.  69%,  p  =  0.78).Discussion
Here,  we  discovered  for  the  ﬁrst  time,  that  the  com-
position  of  intracoronary  thrombotic  material  aspirated
d
V
s
rlycoprotein  (GP)  IIb/IIIa  (platelets)  and  ﬁbrin.  All  drug-eluting
y  thrombectomy  in  AMI  with  LST  or  VLST  is  often  het-
rogeneous  in  terms  of  thrombus  age,  and  that  fresh
hrombus  tends  to  be  more  frequent  in  patients  with  stent
ailure.  Moreover,  we  found  older  thrombi  (lytic  and  orga-
ized  thrombus)  in  69%  of  our  patients,  which  suggests  an
mportant  discrepancy  between  the  time  of  onset  of  the
ntra-stent  thrombotic  process  and  the  appearance  of  acute
linical  symptoms.
Although  DES  has  dramatically  reduced  the  incidence
f  in-stent  restenosis,  a new  life-threatening  problem  of
ST  and  VLST  resulting  in  acute  coronary  syndrome  has
eveloped  [3—7]. The  mechanisms  leading  to  LST  and/or
LST  are  complex  and  incompletely  understood.  Autopsy
tudies  of  thrombosed  DES  specimens  from  humans  have
evealed  delayed  healing,  incomplete  endothelialization,
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In  conclusion,  our  discovery  of  older  thrombi  (lytic  andFigure  3  Age  of  aspirated  thrombus.
hronic  inﬂammation,  and  hypersensitivity  reactions  as  pre-
ailing  pathological  mechanisms  [3,6]. Clinical  studies  have
ound  mural  thrombi  by  follow-up  angioscopy  and  by  opti-
al  coherence  tomography  even  in  asymptomatic  patients
7,16,17],  and  have  demonstrated  that  DES  thrombosis  is
ssociated  with  histopathological  signs  of  inﬂammation  and
VUS  evidence  of  vessel  remodeling  [5].  Higo  et  al.  [7]  also
howed  that  thrombogenic  yellow  plaque  is  also  enhanced
ot  only  in  the  vessel  wall  below  the  stent  but  also  over
ES  after  DES  implantation;  they  suggested  that  thrombo-
enic  plaque  could  constitute  a  potent  substrate  for  ST.
hese  lines  of  evidence  suggest  that  DES  thrombosis  is  a
‘chronic  reaction,’’  and  indicate  a  considerable  interval
etween  DES  thrombosis  and  the  onset  of  symptoms.  How-
ver,  because  of  the  very  low  incidence  of  deﬁnite  LST  and
LST,  few  studies  have  evaluated  when  thrombus  starts  to
orm.  In  contrast,  sudden  coronary  occlusion  resulting  in  de
ovo  AMI  is  often  preceded  by  a  variable  period  of  plaque
nstability  and  thrombus  formation,  and  the  presence  of
lder  thrombus  is  an  independent  predictor  of  long-term
ortality  in  patients  with  AMI  [13—15]. An  angiographic
tudy  also  revealed  that  Ambrose’s  type  II  eccentric  lesions
ndicating  plaque  rupture  and/or  thrombi  and  marked  pro-
ression  in  percent  diameter  stenosis  are  observed  3  days
efore  AMI  [18]. The  present  study  addressed  these  issues
y  aspirating  coronary  thrombus  from  stented  segments
sing  an  ultra-thin  aspiration  catheter.  Thus,  fresh  ST  spec-
mens  could  be  collected  during  the  acute  phase,  avoiding
ost-mortem  histological  changes.  We  discovered  that  the
omposition  of  thrombi  in  a  stented  segment  is  frequently
eterogeneous  in  terms  of  thrombus  age.  Our  results  sup-
ort  previous  ﬁndings  and  indicate  that  in  most  patients
ith  ST,  thrombus  forms  at  least  days  to  weeks  before  an
cute  event  occurs.  In  the  present  study,  we  also  compared
he  incidence  of  older  thrombus  in  de  novo  AMI  patients
ith  that  in  ST  patients.  The  incidence  of  older  thrombus
o
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as  comparable  between  the  two  groups.  And  then,  all
ES  thrombi  were  composed  of  aggregated  platelets  and
brin,  along  with  erythrocytes  and  white  blood  cells  as
ell  as  de  novo  AMI  thrombi,  as  previously  described
11].
Stent  thrombosis  is  a  multifactorial  issue  involving  the
atient,  the  lesion,  and  procedural  factors,  as  well  as  the
oagulation  system  and  response  to  antiplatelet  therapy
3—6].  Stent  failure  including  underexpansion,  malappo-
ition,  and  fracture  also  plays  an  important  role  in  the
evelopment  of  ST,  and  correlates  with  an  increased  risk
or  DES  thrombosis  [3,5,6,17,19]. In  our  study,  stent  fail-
re,  especially  malapposition,  was  evident  in  6  (55%)  of
1  patients  who  underwent  IVUS.  Fresh  thrombus  tended
o  be  identiﬁed  more  frequently  in  these  patients.  Fur-
hermore,  the  interval  between  the  time  of  onset  of  the
hrombotic  process  and  the  occurrence  of  clinical  symptoms
as  shorter  in  patients  who  had  ST  with,  than  those  without
tent  failure.  The  structural  changes  might  propose  contin-
ous  exposure  of  injured  plaques  and  alternation  of  blood
ow  dynamics,  which  not  only  impair  arterial  healing  but
lso  intensively  encourage  the  activation  of  platelets  and
oagulation  pathway  leading  to  focal  thrombus  propagation
20,21].  Therefore,  the  mechanism  of  stent  thrombosis  may
e  different  between  the  patients  with  and  without  stent
ailure.
The  present  study  found  organized  thrombus  (more  than
everal  days)  in  50%  of  patients  with  LST  and  VLST,  which  was
nexpectedly  high.  Drugs  released  from  DES  exert  distinct
iological  effects,  such  as  activating  signal  transduction
athways  and  inhibiting  the  vascular  smooth  muscle  cell
roliferation  and  migration  that  are  key  factors  in  the
evelopment  of  restenosis  [3,6]. However,  we  and  several
nvestigators  have  found  organized  thrombus  with  ingrowing
mooth  muscle  cells  in  patients  not  only  with  DES  restenosis
ut  also  with  ST  [9—11,22].  Additionally,  a recent  patho-
ogical  study  has  demonstrated  that  neoatherosclerosis  with
nstable  features  is  a  frequent  ﬁnding  in  DES  and  the  devel-
pment  of  neoatherosclerosis  may  be  another  contributing
actor  of  late  thrombotic  events  [23]. Thus,  our  results
upport  previous  ﬁndings  and  indicate  that  thrombus  is
radually  propagated  in  a  stented  segment  before  clinical
ymptoms  occur.
The  limitations  of  this  study  are  as  follows.  Firstly,  the
mall  sample  size  might  not  have  been  sufﬁcient  to  reach  a
eﬁnitive  conclusion.  However,  to  recruit  a  large  number  of
atients  is  complicated  by  the  very  low  rates  of  ST.  The  inci-
ence  of  deﬁnite  LST  and  VLST  after  DES  implantation  is  only
.5%  at  our  institutions,  which  is  similar  to  that  of  several
tudies  [3,4,11].  Further  investigations  are  required  to  con-
rm  our  observations.  Secondly,  we  could  not  evaluate  all
omponents  of  culprit  lesions  because  the  aspirated  thrombi
ere  quite  small.  However,  this  method  allows  examina-
ions  of  thrombosed  portions  in  the  absence  of  post-mortem
hanges.  Thirdly,  we  could  not  assess  differences  between
ypes  of  DES.  Finally,  we  could  not  investigate  an  aspirin  and
lopidogrel  resistance  as  blood  samples  from  the  patients
ere  unavailable.rganized  thrombus)  in  most  patients  with  late  and  very
ate  stent  thrombosis,  indicates  that  thrombus  forms  at
east  days  to  weeks  before  an  acute  event  and  provides
te  d
[
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[
[Presence  of  older  thrombus  in  patients  with  late  and  very  la
further  information  about  another  potential  mechanism  of
DES  thrombosis.
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